Kodiak (KDK) news
Recent news
Kodiak AI on track for year-end driverless long-haul launch as autonomy readiness measure jumps to 96%
Kodiak AI (Nasdaq: KDK) is advancing toward its goal of launching driverless long-haul operations by the end of 2026, with its autonomy readiness measure reaching 96% as of the third quarter of the year. The company has made significant progress in integrating its autonomous driving technology into…
AInvest Wire · Oct 6, 2026Kodiak acquires Eco Solution Distributing, entering the water treatment industry and expanding its product portfolio
Kodiak Industries has announced the acquisition of Eco Solution Distributing, a move that marks the company's entry into the water treatment industry and broadens its product offerings. The acquisition is expected to enhance Kodiak’s capabilities in industrial and commercial markets by adding a…
AInvest Wire · Sep 29, 2026Kodiak Sciences shares soar by a record 178%
Kodiak Sciences Inc. (KOD) has seen its shares surge by a record 178% year to date as of September 2026, outperforming the broader biotech sector, which has declined by 0.3% . The stock's strong performance follows the release of positive phase III trial data for its lead candidate, Zenkuda…
AInvest Wire · Sep 28, 2026Kodiak to file Zenkuda 3-indication bla in 40 2026
Kodiak, a biopharmaceutical company, has announced its intention to file a Biologics License Application (BLA) for Zenkuda in the third indication in Q2 2026, as previously disclosed in company communications [1]. This regulatory submission will follow the completion of ongoing clinical trials and…
AInvest Wire · Sep 28, 2026Kodak Sciences Inc. - Zenkuda and Tabirafusp-TED demonstrated safety consistent with established safety profile of aflibercept
Kodiak Sciences Inc. has reported that its investigational therapies, Zenkuda (tarcocimab tedromer) and tabirafusp tedromer (KSI-501), demonstrated safety profiles consistent with those of aflibercept, a widely used anti-VEGF treatment for retinal diseases. These findings emerged from the company’s…
AInvest Wire · Sep 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.